Navigation Links
BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
Date:6/16/2009

QUINCY, Mass., June 16 /PRNewswire/ -- BioEnergy International, LLC (BioEnergy), a privately-held, biotech developer and manufacturer of next-generation, renewable biochemicals and biofuels, announces the formation of Myriant Technologies LLC (Myriant) to incorporate all of its biobased chemicals business and intellectual property. BioEnergy will continue its pursuit of biofuels opportunities, including its 110 million gallon per day ethanol plant in Clearfield, Pennsylvania, currently slated for operation in January. The newly-constituted entities will operate as completely separate companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080211/NEM085LOGO )

The move was made pursuant to the company's continuing emergence in the field of biobased chemicals. "It has become clear over time that we've had two distinct companies operating under the same roof, with different technical requirements and serving different markets and customers," said Stephen J. Gatto, Chairman and Chief Executive Officer. "The new alignment will facilitate a clearer understanding and market valuation of each business for both customers and investors alike."

Myriant will encompass the same world-renowned team of molecular biologists, engineers and chemists that successfully developed BioEnergy's D(-) lactic acid, which started production at commercial scale in June 2008 for use in Polylactic Acid (PLA). D(-) lactic acid solves PLA's thermal stability problem, unlocking the vast potential of PLA by expanding its applications to engineering and high performance plastics. "Our unique combination of extraordinary research and development achievement coupled with commercial execution success sets Myriant apart in this field of huge promise," add
'/>"/>

SOURCE BioEnergy International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
2. Universal Bioenergy, Inc. Expressly Disclaims Any Responsibility for the Content, Accuracy of Information, and Quality of Information Regarding Universal Published by Any Third-Party and Being Disseminated on the Internet
3. Atlantica Bioenergy Task Force hosts industry and government leaders
4. Bioenergy D-Ribose Achieves Highest Safety Standard
5. Media Advisory - Atlantica BioEnergy Task Force Leaders Roundtable
6. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
7. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
8. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
9. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
10. Raj Khankari Named Bioenergy, Inc., CEO
11. Atlantica BioEnergy Task Force Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)... 2015  Derma Sciences, Inc. (Nasdaq: DSCI ... wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic ... to the Premier, Inc. Regenerative Skin Grafting contract ... AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, ... in critical areas, announced the closing of an underwritten public ... purchase up to an aggregate 3,500,000 shares of common stock, ... per warrant.  The warrants have a per share exercise price ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Nutrition 21, Inc.,(Nasdaq: NXXI ) today announced ... general manager of the Company,s Direct Response Group,effective ... 22 years of,experience in sales, marketing, management and ... responsibilities include new,business development, sales strategy, vendor operations ...
... ROCKVILLE, Md., Oct. 30 Human Genome,Sciences, Inc. (Nasdaq: ... a,conference call to discuss its financial results for the ... be disclosed on Thursday,November 6, 2008, after the capital ... The conference call will be hosted by senior management ...
... 30 Oramed Pharmaceuticals,Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), ... Chief Executive Officer, Mr. Nadav,Kidron, will be giving a ... Conference at New York City,s Palace Hotel on November,11. ... 4:30 in the Kennedy II,Ballroom, located on the 4th ...
Cached Biology Technology:Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response 2Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response 3Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results 2Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC) 2
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... of the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 This ... media watermarking and fingerprinting markets. Watermarking aims to ...
(Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today its completion ... its adherence to current U.S. Food and Drug Administration ... smart device and smart phone application trials utilizing the ... "HITLAB is determined to improve global healthcare access, ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... research found that snoring is in fact part of ... condition looks and sounds similar in adults and children ... , The study published in the latest edition of ... with rhinitis who were first born, were exposed to ...
... more genetic markers in the DNA of people ... has enabled researchers to identify a common gene ... developing Alzheimer’s disease. The finding, announced today by ... Banner Alzheimer’s Institute, Kronos Science Laboratory and their ...
... Georgetown University Medical Center say they are moving closer ... malaria has become resistant to drug treatment in the ... construct, and then express in yeast, a protozoan gene ... small feat. The gene they laboriously constructed over a ...
Cached Biology News:Snoring in children might be an allergic type disease 2Research team identifies new Alzheimer's gene 2Research team identifies new Alzheimer's gene 3Largest synthetic gene ever built offers insights into anti-malarial drug resistance 2Largest synthetic gene ever built offers insights into anti-malarial drug resistance 3Largest synthetic gene ever built offers insights into anti-malarial drug resistance 4
Request Info...
... Immunogen: Synthetic peptide derived from the ... mouse protein kinase C zeta isoform (PKCzeta). ... mouse PKCzeta protein. Recognizes PKCzeta and ... with PKCiota/lambda. Reactivity: Mouse Rat (positive ...
Request Info...
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
Biology Products: